{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.5, "epsForward": -0.61, "epsCurrentYear": -0.55, "priceEpsCurrentYear": -0.28727272, "sharesOutstanding": 89422096, "bookValue": -0.213, "fiftyDayAverage": 0.149096, "fiftyDayAverageChange": 0.00890401, "fiftyDayAverageChangePercent": 0.05971998, "twoHundredDayAverage": 0.702479, "twoHundredDayAverageChange": -0.544479, "twoHundredDayAverageChangePercent": -0.77508223, "marketCap": 14962902, "forwardPE": -0.2590164, "priceToBook": -0.7417841, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.9 - Buy", "tradeable": false, "cryptoTradeable": false, "currency": "EUR", "financialCurrency": "USD", "regularMarketOpen": 0.1616, "averageDailyVolume3Month": 245, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.06840001, "fiftyTwoWeekLowChangePercent": 0.763393, "fiftyTwoWeekRange": "0.0896 - 1.6818", "fiftyTwoWeekHighChange": -1.5238, "fiftyTwoWeekHighChangePercent": -0.90605307, "fiftyTwoWeekLow": 0.0896, "fiftyTwoWeekHigh": 1.6818, "earningsTimestamp": 1680033900, "earningsTimestampStart": 1685995200, "earningsTimestampEnd": 1687291200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1158732000000, "priceHint": 4, "marketState": "REGULAR", "regularMarketChange": -0.003399998, "regularMarketTime": 1683899564, "regularMarketDayHigh": 0.1616, "regularMarketDayRange": "0.158 - 0.1616", "regularMarketDayLow": 0.158, "regularMarketVolume": 12500, "regularMarketPreviousClose": 0.1614, "bid": 0.1528, "ask": 0.173, "bidSize": 5200, "askSize": 5200, "fullExchangeName": "Frankfurt", "regularMarketChangePercent": -2.1065662, "regularMarketPrice": 0.158, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "FRA", "shortName": "INFINITY PHARMAC. DL-,001", "longName": "Infinity Pharmaceuticals, Inc.", "messageBoardId": "finmb_1208927", "market": "dr_market", "symbol": "I3F.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1100 Massachusetts Avenue", "address2": "Floor 4", "city": "Cambridge", "state": "MA", "zip": "02138", "country": "United States", "phone": "(617) 453-1000", "fax": "(617) 453-1001", "website": "https://www.infi.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. Infinity Pharmaceuticals, Inc. has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Ms. Adelene Q. Perkins", "age": 62, "title": "Chairman & CEO", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 701507, "fmt": "701.51k", "longFmt": "701,507"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Robert  Ilaria Jr., M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 653797, "fmt": "653.8k", "longFmt": "653,797"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Lawrence E. Bloch J.D., M.D.", "age": 56, "title": "Treasurer", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 513610, "fmt": "513.61k", "longFmt": "513,610"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Melissa  Hackel", "title": "VP of Fin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Stephane  Peluso Ph.D.", "age": 51, "title": "Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Seth A. Tasker J.D.", "age": 43, "title": "Sr. VP, Chief Bus. Officer, Gen. Counsel & Sec.", "yearBorn": 1979, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}